Cancer News and Research

Latest Cancer News and Research

New publication explains role of standards-based interoperable digital identities in healthcare

A new publication explains how standards-based interoperable digital identities are needed to transform healthcare to a paperless and fully electronic business environment. It is being issued in conjunction with the annual meeting of Healthcare Information and Management Systems Society (HIMSS), February 20-24 in Las Vegas.

18 Feb 2012

Celebrity Nutritionist endorses Pure Health's Black Raspberry supplement

Pure Health's fresh freeze dried 100 percent pure Black Raspberry capsule supplements have earned the endorsement by Celebrity Nutritionist Dr. Lindsey Duncan, CN, ND, who recently appeared on a major national TV show talking about the benefits of fresh freeze dried Black Raspberry to support cancer prevention.

18 Feb 2012

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that, as anticipated, on February 15, 2012, the Company was notified by The NASDAQ Stock Market that because the Company has not regained compliance with the $1.00 minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before a NASDAQ Hearings Panel.

18 Feb 2012

EMA CHMP recommends CTI's Pixuvri for conditional approval

Cell Therapeutics, Inc. announced today that Pixuvri has been granted a positive opinion for conditional approval from the European Medicines Agency's Committee for Medicinal Products for Human Use.

18 Feb 2012

UH's Eye Institute receives $5M Elisabeth Severance Prentiss Foundation gift

The Elisabeth Severance Prentiss Foundation again has demonstrated its commitment to University Hospitals (UH) with a $5 million gift for the Eye Institute. The gift will honor the late Benjamin L. Millikin, MD, husband of Julia Severance and the grandfather of Prentiss Foundation trustee Elisabeth Alexander.

18 Feb 2012

CentraState chooses Cognizant to develop ICD-10 transition strategy

Cognizant, a leading provider of information technology, consulting, and business process outsourcing services, today announced that it has been selected by CentraState Healthcare System, a leading not-for-profit community health organization, to develop a strategy for transitioning to ICD-10.

18 Feb 2012

Women with heart problems at higher cancer risk after Omega-3 and vitamin B supplementation

However, women with a previous history of cardiovascular pathologies seem to have a higher cancer risk after five years of supplementation. The research is published in detail in the Archives of Internal Medicine.

18 Feb 2012

Votes expected today on 'doc fix' compromise bill

The legislation, which also extends a payroll tax holiday and unemployment benefits, is a rare sign of bipartisanship within the 112th Congress, though not everyone is happy with the deal.

18 Feb 2012

MDC publishes latest research report on cardiovascular and metabolic diseases

The Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch, which celebrates its 20th anniversary this year, has published its latest research report. In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charit- - Universit-tsmedizin Berlin give an overview of their work in 2010 - 2011.

18 Feb 2012

RAD51 gene behind the cause of congenital mirror movements

Further work carried out on mice suggests that this gene plays a part in motor network cross-over. Cross-over is a key factor in the transmission of brain signals, because it allows the right side of the brain to control the left side of the body and vice versa. This research has been published in The American Journal of Human Genetics.

18 Feb 2012

Study reveals immune mechanism for surveillance over EBV infection

Some 90 percent of people are exposed to the Epstein Barr virus (EBV) at some point in their life. Even though it is quickly cleared from the body, the virus can linger silently for years in small numbers of infected B cells.

18 Feb 2012

Evolutionary biologist receives LRI grant for lupus research

Evolutionary biologist Harmit Singh Malik, Ph.D., of Fred Hutchinson Cancer Research Center, has received a $300,000 grant from the Lupus Research Institute to study the potential role of "genetic conflicts" in the development of lupus, an autoimmune disease.

18 Feb 2012

Asuragen introduces miRInform test for diagnosis of pancreatic ductal adenocarcinoma

Asuragen, Inc. announced today the immediate availability of the miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. miRInform® Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. The test evaluates expression levels of seven miRNAs in Fine Needle Aspirate (FNA) specimens of pancreatic masses.

17 Feb 2012

Abcodia, Volition announce collaboration agreement

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement with Abcodia, a specialist company spun out from University College London (UCL), under which Volition will gain access to Abcodia's biobank of over 5,000,000 human serum samples to validate its suite of NuQ tests.

17 Feb 2012

IHP, PFCD organize expert roundtable on NCDs at New Delhi

India Health Progress (IHP) in association with Partnership to Fight Chronic Disease (PFCD) today organized an expert roundtable on 'Non-Communicable Diseases Burden in India: Strategizing the Way Forward' at Taj Mahal Hotel, New Delhi.

17 Feb 2012

UK's leading model agencies back 'No Sunbed' campaign

Ahead of London Fashion Week, leading model agencies sign groundbreaking 'No Sunbed' policy agreement as part of Cancer Research UK's R UV UGLY? campaign after warnings on health and appearance

17 Feb 2012

Lung cancer patients with severe COPD can benefit from SBRT

Stereotactic body radiotherapy (SBRT) provides better overall survival rates than surgery for lung cancer patients with severe chronic obstructive pulmonary disease (COPD), a disease commonly associated with lung cancer, according to a study in the upcoming March issue of the International Journal of Radiation, Oncology, Biology, Physics, the official scientific journal of the American Society for Radiation Oncology.

17 Feb 2012

Study reveals new guiding principles for cancer genomics

That our chromosomes can break and reshuffle pieces of themselves is nothing new; scientists have recognized this for decades, especially in cancer cells. The rules for where chromosomes are likely to break and how the broken pieces come together are only just now starting to come into view.

17 Feb 2012

New potential strategy for KRAS-mutant colon cancers

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted treatments.

17 Feb 2012

Study describes how multiple RNA binding proteins cooperatively control genetic splicing code

Understanding how RNA binding proteins control the genetic splicing code is fundamental to human biology and disease - much like editing film can change a movie scene. Abnormal variations in splicing are often implicated in cancer and genetic neurodegenerative disorders.

17 Feb 2012